ライフサイエンスコーパス: balloon dilation

1 tients, 72 vessels responded to low-pressure balloon dilation.

2 omy and one of three (33%) treated with only balloon dilation.

3 intrahepatic portal vein and with subsequent balloon dilation.

4 Animals were euthanized 28 days after balloon dilation.

5 meter occurred in four of six patients after balloon dilation.

6 te recurrent TEF related to the early use of balloon dilation.

7 ated in dogs by blade septostomy followed by balloon dilation.

8 theterizations, one of which required repeat balloon dilation 47 days after infiltration.

9 terventions included branch pulmonary artery balloon dilation (7 patients, 23 vessels) and coil embol

10 ne patients (>10 years old) with COA in whom balloon dilation alone was thought to be ineffective und

11 tents and in 21 of 27 patients (78%) who had balloon dilation alone.

12 better clinical or angiographic results than balloon dilation alone.

13 This complication can be treated with balloon dilation, although the long-term course is unkno

14 ents undergoing preoperative pulmonary valve balloon dilation, among other transcatheter intervention

15 (n = 12) were treated in separate zones with balloon dilation and balloon dilation plus laser illumin

16 nosis can be readily treated with endoscopic balloon dilation and should be the first-line therapy.

17 nderwent coronary stenting, as required, and balloon dilation and were then randomly assigned to rece

18 c tissue and only 23% occurred after adjunct balloon dilation, and further stent expansion did not co

19 used for MR imaging-guided catheterization, balloon dilation, and stent implantation into aorto-ilia

20 lusion failed to respond to nitroglycerin or balloon dilation, and stenting was required in both case

21 cal and severe pulmonary stenosis (PS) after balloon dilation, and to determine any morphometric or h

22 proaches the reported rates of patency after balloon dilation as part of percutaneous graft recanaliz

23 rs of pulmonary regurgitation (PR) following balloon dilation (BD) for pulmonary stenosis (PS) and to

24 riencing pulmonary artery (PA) trauma during balloon dilation (BD).

25 uits that are only temporarily relieved with balloon dilation can be effectively expanded with intrav

26 images from within commercially available 5F balloon dilation catheters.

27 ectrum of patients and practices, endoscopic balloon dilation compared with sphincterotomy for biliar

28 roscopic Heller myotomy (LHM) and endoscopic balloon dilation (EBD) considering the need for retreatm

29 c botulin toxin injection (EBTI), endoscopic balloon dilation (EBD), and surgical myotomy with or wit

30 ith endoscopic sphincterotomy and endoscopic balloon dilation (EBD).

31 fects and complications of endoscopic-guided balloon dilations (EBD) in patients with corrosive-induc

32 ) surgically, (c) with endoscopically guided balloon dilation (EGBD), (d) with FGBD, or (e) medically

33 tomy (PS) combined with endoscopic papillary balloon dilation (EPBD) for CBD stone removal in patient

34 doscopic sphincterotomy/endoscopic papillary balloon dilation (EST/EPBD) with negative ERC finding.

35 w of 148 children >1 month old who underwent balloon dilation for aortic stenosis.

36 luated the efficacy of a protocol of initial balloon dilation for biliary strictures after liver tran

37 from 1985 to 2008, 563 patients underwent balloon dilation for congenital AS.

38 imilar or slightly superior acute results of balloon dilation for native compared with recurrent CoA.

39 the site with stent deployment before using balloon dilation for optimal gain in lumen diameter.

40 phasize biliary sphincterotomy compared with balloon dilation for the management of choledocholithias

41 Balloon dilation has been used as an alternative to surg

42 nderwent aortic valve reintervention: repeat balloon dilation in 115 (23%), aortic valve repair in 65

43 the respective clinical roles of surgery and balloon dilation in the management of CoA.

44 pulmonary arteries, initial pulmonary valve balloon dilation increases the annulus Z score and anter

45 wall surface, intended to correspond to the balloon dilation-induced vascular injury and healing pro

46 f juvenile domestic pigs underwent oversized balloon dilation injury of the left anterior descending

47 activity and neointimal formation induced by balloon dilation injury.

48 Balloon dilation is a new treatment for congenital aorti

49 eptoplasty consisting of septal puncture and balloon dilation is feasible and can be performed percut

50 nly 7 (5%) patients required reintervention (balloon dilation, n=5; surgery, n=2).

51 Balloon dilation of congenital and acquired tracheal and

52 istics that influence the midterm success of balloon dilation of congenital aortic stenosis.

53 iate and midterm (mean 4.3 years) results of balloon dilation of critical valvular aortic stenosis in

54 ibitors to inhibit intimal hyperplasia after balloon dilation of noncoronary arteries in small-animal

55 Experience of balloon dilation of peripheral pulmonary stenosis (PPS)

56 ine the short and long-term success rates of balloon dilation of pyloric stenosis.

57 re outcomes after surgical valvuloplasty and balloon dilation of the aortic valve in neonates and inf

58 (s)=1.7+/-0.2) was created percutaneously by balloon dilation of the fossa ovalis.

59 Balloon dilation of the PA is important in the managemen

60 determine short-term outcomes of endoscopic balloon dilation of the sphincter of Oddi compared with

61 Balloon dilation of the sphincter of Oddi for stone extr

62 Balloon dilation of the stenotic pulmonary veins was per

63 ial septum was successfully perforated, with balloon dilation of this iatrogenic defect resulting in

64 asty, although stenosis resistant to further balloon dilation or regurgitation may develop, necessita

65 n did not differ between patients undergoing balloon dilation or stent implantation, but was longer i

66 od, recognizing the need for reintervention (balloon dilation or surgery) in a significant proportion

67 Seven patients had a previous operation or balloon dilation, or both, to relieve their coarctation

68 1977, to April 1, 2007, percutaneous biliary balloon dilation (PBBD) was performed in 85 patients wit

69 in separate zones with balloon dilation and balloon dilation plus laser illumination.

70 Twenty-three incremental balloon dilation procedures were performed in these six

71 ar ultrasound (IVUS) studies performed after balloon dilation provide a method for evaluating the ade

72 In all vessels, low-pressure balloon dilation to 8 atm was performed, and if it was n

73 ageal echocardiography, underwent additional balloon dilation to correct aortic regurgitation.

74 Balloon dilation was a safe and effective palliative pro

75 n occurred in 20 patients in whom additional balloon dilation was successful but did not occur in the

76 Balloon dilation was successful in 87% of patients, with

77 Results Balloon dilation was technically successful in all 52 st

78 Second transcatheter interventions (4 SP, 4 balloon dilation) were successful in 8 of 13 patients.

79 Eradication of this infection at the time of balloon dilation will ensure higher long-term success ra

80 Balloon dilation with fluoroscopic guidance is a safe an

81 -six patients (mean age, 51 years) underwent balloon dilation with radiologic guidance.